Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 04, 2015 11:38 AM ET


Company Overview of Sygnis Pharma AG, Prior to Reverse Merger with X-Pol Biotech S.L.

Executive Profile

Peter Seeburg Ph.D.

AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships


Dr. Peter Seeburg Ph.D. serves as Member of Scientific Advisory Board of Agy Therapeutics, Inc. Dr. Seeburg is a Professor of Molecular Biology at the University of Heidelberg in Germany, and currently Director of the Department for Molecular Neurobiology at the Max Planck Institute for Medical Research. He served as Member of Scientific Advisory Board of Sygnis Pharma AG. Dr. Seeburg was an early pioneer in biotechnology at Genentech, and is one of the most cited authors ...

Corporate Headquarters

Im Neuenheimer Feld 515
Heidelberg, Baden-Württemberg 69120


Phone: 49 6221 454 6
Fax: 49 6221 454 700

Board Members Memberships

There is no Board Members Memberships data available.


There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sygnis Pharma AG, Prior to Reverse Merger with X-Pol Biotech S.L., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at